Hologic Inc HOLX:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/26/21 EST
72.09quote price arrow down-0.27 (-0.37%)
Volume
2,234,237
52 week range
26.49 - 85.00

...

Loading . . .

KEY STATS

  • Open72.49
  • Day High72.96
  • Day Low71.40
  • Prev Close72.09
  • 52 Week High85.00
  • 52 Week High Date02/16/21
  • 52 Week Low26.49
  • 52 Week Low Date03/18/20
  • Market Cap18.575B
  • Shares Out257.66M
  • 10 Day Average Volume2.56M
  • Dividend-
  • Dividend Yield-
  • Beta1.20
  • 1 Year % Change51.16

RATIOS/PROFITABILITY

  • EPS (TTM)5.27
  • P/E (TTM)13.67
  • Fwd P/E (NTM)8.83
  • EBITDA (MRQ)2.26B
  • ROE (MRQ)50.14%
  • Revenue (MRQ)4.536B
  • Gross Margin (MRQ)65.57%
  • Net Margin (MRQ)30.39%
  • Debt To Equity (MRQ)85.17%

EVENTS

  • Earnings Date04/27/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest HOLX News From Our Partners

QUOTE FINDER

Profile

MORE
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B...
Stephen Macmillan
Chairman
Karleen Oberton
Chief Financial Officer
John Griffin
General Counsel
Address
250 Campus Dr
Marlborough, MA
01752-3020
United States